T cell activity after dendritic cell vaccination is dependent on both the type of antigen and the mode of delivery

Jonathan S. Serody, Edward J. Collins, Roland M. Tisch, Jennifer J. Kuhns, Jeffrey A. Frelinger

Research output: Contribution to journalArticlepeer-review

73 Scopus citations

Abstract

Previous work in both human and animal models has shown that CTL responses can be generated against proteins derived from tumors using either peptide-pulsed dendritic cells (DCs) or nucleic acids from the tumor transfected into autologous DCs. Despite the efficacy of this approach for vaccine therapy, many questions remain regarding whether the route of administration, the frequency of administration, or the type of Ag is critical to generating T cell responses to these Ags. We have investigated methods to enhance CTL responses to a peptide derived from the human proto- oncogene HER-2/neu using mice containing a chimeric HLA A2 and H2Kb allele. Changes in amino acids in the anchor positions of the peptide enhanced the binding of the peptide to HLA-A2 in vitro, but did not enhance the immunogenicity of the peptide in vivo. In contrast, when autologous DCs presented peptides, significant CTL activity was induced with the altered, but not the wild-type, peptide. We found that the route of administration affected the anatomic site and the time to onset of CTL activity, but did not impact on the magnitude of the response. To our surprise, we observed that weekly administration of peptide-puked DCs led to diminishing CTL activity after 6 wk of treatment. This was not found in animals injected with DCs every 3 wk for six treatments or in animals initially given DCs weekly and then injected weekly with peptide-pulsed C1R-A2 transfectants.

Original languageEnglish (US)
Pages (from-to)4961-4967
Number of pages7
JournalJournal of Immunology
Volume164
Issue number9
DOIs
StatePublished - May 1 2000

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Fingerprint

Dive into the research topics of 'T cell activity after dendritic cell vaccination is dependent on both the type of antigen and the mode of delivery'. Together they form a unique fingerprint.

Cite this